Le Lézard
Classified in: Health, Science and technology, Business
Subjects: CON, VET, SBS

Knowesis Awarded Expanded Clinical Research And Analytic Support Contract In Support Of Joint Trauma System


FAIRFAX, Va., Oct. 4, 2017 /PRNewswire/ -- Knowesis, Inc. has acquired new work supporting the U.S. Army Institute of Surgical Research's (USAISR) Joint Trauma System's (JTS) ongoing efforts to increase combat casualty care capability through research and analytic support. Knowesis is pleased to expand its ongoing support within the USAISR environment and lend its expertise in strengthening and growing Army knowledge of trauma care delivery.

Knowesis Inc. - Data Driven Decisions (PRNewsFoto/Knowesis, Inc.)

Under this contract, Knowesis will assist USAISR in providing project support, research collaboration, data collection and analysis, statistical design support, prepare study protocols and develop and submit/present reports, presentations, and abstracts based upon the findings.

"We are excited to expand our efforts in supporting the JTS and the USAISR.  We are honored to work with  this amazing organization that continues to be a worldwide leader in innovations of healthcare to our nation's heroes.  The critical work accomplished by the JTS has resulted in countless lives saved and we are proud to be a part of this team," said A. Scott Cooper, Program Manager.

Knowesis specializes in solving business challenges through strategic planning and capacity building, evaluation and data analysis, strategic communications, enterprise reporting and program management. Knowesis applies our core functional competencies to the healthcare industry and are highly integrated within the USAISR clinical research environment. Our staff of dedicated professionals are recognized for bringing valuable experience from a variety of sectors, crossing industries and the Federal Government.

Knowesis Inc., as a Center for Veterans Enterprise (CVE) certified Service Disabled Veteran Owned Small Business (SDVOSB), 8(a) Disadvantaged Small Business and Economically Disadvantaged Woman Owned Small Business (EDWOSB), provides a full range of professional consulting services to federal and state government agencies. Founded in 2007, Knowesis offers services in analytics and information management, planning and operations, as well as communication and engagement from its offices in San Antonio, TX and Fairfax, VA. More information about the company can be found at www.knowesis-inc.com as well as Facebook and Twitter.

SOURCE Knowesis, Inc.


These press releases may also interest you

at 01:10
HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused on long non-coding RNAs (lncRNAs), today announced that HAYA's Co-Founders Samir Ounzain and Daniel Blessing have received the inaugural Andreas & Thomas...

at 01:05
The committee of the newly established Andreas & Thomas Struengmann Award today announced that Samir Ounzain and Daniel Blessing, the two co-founders of HAYA Therapeutics, are the inaugural winners of the Andreas & Thomas Struengmann Award....

at 01:05
ReCerise Therapeutics Inc. (CEO Yong-Bae Kim), has announced its selection for a grant from the Ministry of Trade, Industry and Energy (MOTIE) of South Korea. The grant aims to support the development of tailored targeted therapies for refractory...

at 01:00
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules FDA approves biosimilar PyzchivaŽ (ustekinumab-ttwe), to be commercialized by Sandoz in US PyzchivaŽ (ustekinumab-ttwe) is approved by FDA for all indications of reference...

at 01:00
Education Cannot Wait (ECW) and the Aga Khan Foundation (AKF) announce an expanded three-year partnership that will improve holistic quality learning outcomes and quality learning environments for crisis-affected learners in Afghanistan, Pakistan and...

30 jun 2024
SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today announced that U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug...



News published on and distributed by: